As the Rare Neurological Disease Treatment Market continues to evolve, experts predict revolutionary trends that could reshape the treatment landscape significantly. The market is expected to reach a staggering $20.76 billion by 2035, reflecting a compound annual growth rate (CAGR) of 6.09%. This growth trajectory is underpinned by a surge in awareness surrounding rare neurological diseases,...